A Study of the Safety, Tolerability, and Efficacy of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Public ClinicalTrials.gov record NCT02275351. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle- Controlled Study of the Safety, Tolerability, and Efficacy of 0.15% and 0.25% Concentrations of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Study identification
- NCT ID
- NCT02275351
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Biosplice Therapeutics, Inc.
- Industry
- Enrollment
- 310 participants
Conditions and interventions
Conditions
Interventions
- SM04554 Drug
- Vehicle Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 31, 2014
- Primary completion
- Oct 31, 2015
- Completion
- Oct 31, 2015
- Last update posted
- Feb 16, 2020
2014 – 2015
United States locations
- U.S. sites
- 24
- U.S. states
- 15
- U.S. cities
- 23
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Encinitas | California | 92024 | — |
| Not listed | San Diego | California | 92123 | — |
| Not listed | New Haven | Connecticut | 06511 | — |
| Not listed | Miami | Florida | 33143 | — |
| Not listed | West Palm Beach | Florida | 33401 | — |
| Not listed | Plainfield | Indiana | — | — |
| Not listed | Wichita | Kansas | 67207 | — |
| Not listed | Clinton Township | Michigan | 48038 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Fridley | Minnesota | 55432 | — |
| Not listed | Albuquerque | New Mexico | 87106 | — |
| Not listed | New York | New York | — | — |
| Not listed | Stony Brook | New York | 11790 | — |
| Not listed | Winston-Salem | North Carolina | 27104 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Portland | Oregon | 97223 | — |
| Not listed | Austin | Texas | 78759 | — |
| Not listed | College Station | Texas | 77845 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Salt Lake City | Utah | 84117 | — |
| Not listed | Lynchburg | Virginia | 24501 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02275351, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2020 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02275351 live on ClinicalTrials.gov.